On January 24th, 2024, the Uzbekistan-China Pharmaceutical Cooperation Policy and Project Meeting was held in the Futian District of Shenzhen, China. Mr.Tashpulatovu F.M., the deputy minister of health of Uzbekistan, and Mr. Azizov Abdullo, the director of the Pharmaceutical Development Bureau attended the meeting.
During the event, Uzbekistan's representatives provided an overview of the current development status, existing medical conditions, and prospects within their country's healthcare sector. They also discussed investment opportunities and the potential of further collaboration with Chinese companies.
Following the official part of the program, Dymind, a leading hematology analyzer brand in Uzbekistan, had an exclusive opportunity to engage in deep discussions with Mr. Tashpulatovu F.M. and Mr. Azizov Abdullo. These discussions centered on the company's local growth and its future expansion plans in Uzbekistan.
The event was a significant milestone in strengthening the bond between Uzbekistan and China in the field of pharmaceutical development and cooperation. It provided a platform for exchanging ideas, networking, and exploring potential collaborations that could lead to mutual growth and advancement in healthcare for both nations.